OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Prognostic relevance of tumor-infiltrating lymphocytes and immune checkpoints in pediatric medulloblastoma
Jeroen F. Vermeulen, Wim Van Hecke, Elisabeth J. M. Adriaansen, et al.
OncoImmunology (2017) Vol. 7, Iss. 3, pp. e1398877-e1398877
Open Access | Times Cited: 83
Jeroen F. Vermeulen, Wim Van Hecke, Elisabeth J. M. Adriaansen, et al.
OncoImmunology (2017) Vol. 7, Iss. 3, pp. e1398877-e1398877
Open Access | Times Cited: 83
Showing 26-50 of 83 citing articles:
DIMEimmune: Robust estimation of infiltrating lymphocytes in CNS tumors from DNA methylation profiles
Sepehr Safaei, Malte Mohme, Judith Niesen, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 24
Sepehr Safaei, Malte Mohme, Judith Niesen, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 24
Pediatric medulloblastoma express immune checkpoint B7-H3
S. Li, Geke C. Poolen, L. C. van Vliet, et al.
Clinical & Translational Oncology (2022) Vol. 24, Iss. 6, pp. 1204-1208
Open Access | Times Cited: 17
S. Li, Geke C. Poolen, L. C. van Vliet, et al.
Clinical & Translational Oncology (2022) Vol. 24, Iss. 6, pp. 1204-1208
Open Access | Times Cited: 17
EphA2 and phosphoantigen-mediated selective killing of medulloblastoma by γδT cells preserves neuronal and stem cell integrity
Lola Boutin, Mingzhi Liu, Julie Déchanet‐Merville, et al.
OncoImmunology (2025) Vol. 14, Iss. 1
Open Access
Lola Boutin, Mingzhi Liu, Julie Déchanet‐Merville, et al.
OncoImmunology (2025) Vol. 14, Iss. 1
Open Access
Immune cell infiltration and cytokine secretion analysis reveal a non-inflammatory microenvironment of medulloblastoma
Shuo Diao, Chunyu Gu, Hongwei Zhang, et al.
Oncology Letters (2020) Vol. 20, Iss. 6, pp. 1-1
Open Access | Times Cited: 25
Shuo Diao, Chunyu Gu, Hongwei Zhang, et al.
Oncology Letters (2020) Vol. 20, Iss. 6, pp. 1-1
Open Access | Times Cited: 25
Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and Treatment
Rebecca M. Hill, Sabine Plasschaert, Beate Timmermann, et al.
Cancers (2021) Vol. 14, Iss. 1, pp. 126-126
Open Access | Times Cited: 21
Rebecca M. Hill, Sabine Plasschaert, Beate Timmermann, et al.
Cancers (2021) Vol. 14, Iss. 1, pp. 126-126
Open Access | Times Cited: 21
Cellular immunotherapy for medulloblastoma
Michael Y. Schakelaar, Matthijs Monnikhof, Sandra Crnko, et al.
Neuro-Oncology (2022) Vol. 25, Iss. 4, pp. 617-627
Open Access | Times Cited: 15
Michael Y. Schakelaar, Matthijs Monnikhof, Sandra Crnko, et al.
Neuro-Oncology (2022) Vol. 25, Iss. 4, pp. 617-627
Open Access | Times Cited: 15
The pivotal role of irradiation‐induced apoptosis in the pathogenesis and therapy of medulloblastoma
Seidu A. Richard
Cancer Reports (2024) Vol. 7, Iss. 4
Open Access | Times Cited: 3
Seidu A. Richard
Cancer Reports (2024) Vol. 7, Iss. 4
Open Access | Times Cited: 3
New Approaches in Targeted Therapy for Medulloblastoma in Children
H. Maier, Tina Dalianis, Ourania N. Kostopoulou
Anticancer Research (2021) Vol. 41, Iss. 4, pp. 1715-1726
Open Access | Times Cited: 20
H. Maier, Tina Dalianis, Ourania N. Kostopoulou
Anticancer Research (2021) Vol. 41, Iss. 4, pp. 1715-1726
Open Access | Times Cited: 20
Immunotherapy in Medulloblastoma: Current State of Research, Challenges, and Future Perspectives
Marije J. Voskamp, Shuang Li, Kim Robin van Daalen, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5387-5387
Open Access | Times Cited: 19
Marije J. Voskamp, Shuang Li, Kim Robin van Daalen, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5387-5387
Open Access | Times Cited: 19
Digital expression profile of immune checkpoint genes in medulloblastomas identifies CD24 and CD276 as putative immunotherapy targets
Rui Ferreira Marques, Daniel Antunes Moreno, Luciane da Silva, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Rui Ferreira Marques, Daniel Antunes Moreno, Luciane da Silva, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Epigenetics and immune cells in medulloblastoma
Francesca Gorini, Marco Miceli, Pasqualino de Antonellis, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 8
Francesca Gorini, Marco Miceli, Pasqualino de Antonellis, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 8
Exploring the Molecular Complexity of Medulloblastoma: Implications for Diagnosis and Treatment
Julian S. Rechberger, Stephanie Toll, Wouter J. F. Vanbilloen, et al.
Diagnostics (2023) Vol. 13, Iss. 14, pp. 2398-2398
Open Access | Times Cited: 8
Julian S. Rechberger, Stephanie Toll, Wouter J. F. Vanbilloen, et al.
Diagnostics (2023) Vol. 13, Iss. 14, pp. 2398-2398
Open Access | Times Cited: 8
Pediatric Brain Tumours: Lessons from the Immune Microenvironment
Betty Yao, Alberto Delaidelli, Hannes Vogel, et al.
Current Oncology (2023) Vol. 30, Iss. 5, pp. 5024-5046
Open Access | Times Cited: 7
Betty Yao, Alberto Delaidelli, Hannes Vogel, et al.
Current Oncology (2023) Vol. 30, Iss. 5, pp. 5024-5046
Open Access | Times Cited: 7
Preoperative Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio are Associated with the Prognosis of Group 3 and Group 4 Medulloblastoma
Ke Li, Wenchao Duan, Haibiao Zhao, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 21
Ke Li, Wenchao Duan, Haibiao Zhao, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 21
Biological Role of MYCN in Medulloblastoma: Novel Therapeutic Opportunities and Challenges Ahead
Sumana Shrestha, Alaide Morcavallo, Chiara Gorrini, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 18
Sumana Shrestha, Alaide Morcavallo, Chiara Gorrini, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 18
Immunosuppression in Medulloblastoma: Insights into Cancer Immunity and Immunotherapy
Zahraa F. Audi, Zahraa Saker, Mahdi Rizk, et al.
Current Treatment Options in Oncology (2021) Vol. 22, Iss. 9
Closed Access | Times Cited: 17
Zahraa F. Audi, Zahraa Saker, Mahdi Rizk, et al.
Current Treatment Options in Oncology (2021) Vol. 22, Iss. 9
Closed Access | Times Cited: 17
Rethinking medulloblastoma from a targeted therapeutics perspective
Yuuri Hashimoto, Marta Peñas-Prado, Shouhao Zhou, et al.
Journal of Neuro-Oncology (2018) Vol. 139, Iss. 3, pp. 713-720
Open Access | Times Cited: 20
Yuuri Hashimoto, Marta Peñas-Prado, Shouhao Zhou, et al.
Journal of Neuro-Oncology (2018) Vol. 139, Iss. 3, pp. 713-720
Open Access | Times Cited: 20
Immune cell landscape and immunotherapy of medulloblastoma
Jin Zhang, Tianyou Wang
Pediatric Investigation (2021) Vol. 5, Iss. 4, pp. 299-309
Open Access | Times Cited: 15
Jin Zhang, Tianyou Wang
Pediatric Investigation (2021) Vol. 5, Iss. 4, pp. 299-309
Open Access | Times Cited: 15
The Growing Relevance of Immunoregulation in Pediatric Brain Tumors
Viktoria Melcher, Kornelius Kerl
Cancers (2021) Vol. 13, Iss. 22, pp. 5601-5601
Open Access | Times Cited: 15
Viktoria Melcher, Kornelius Kerl
Cancers (2021) Vol. 13, Iss. 22, pp. 5601-5601
Open Access | Times Cited: 15
Immunobiology and Cytokine Modulation of the Pediatric Brain Tumor Microenvironment: A Scoping Review
Shreya Budhiraja, Hinda Najem, Shashwat Tripathi, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3655-3655
Open Access | Times Cited: 6
Shreya Budhiraja, Hinda Najem, Shashwat Tripathi, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3655-3655
Open Access | Times Cited: 6
Oncolytic virus-driven immune remodeling revealed in mouse medulloblastomas at single cell resolution
Jack Hedberg, Adam Studebaker, L.T. Smith, et al.
Molecular Therapy — Oncolytics (2023) Vol. 30, pp. 39-55
Open Access | Times Cited: 6
Jack Hedberg, Adam Studebaker, L.T. Smith, et al.
Molecular Therapy — Oncolytics (2023) Vol. 30, pp. 39-55
Open Access | Times Cited: 6
Opportunities and Advances in Radiomics and Radiogenomics for Pediatric Medulloblastoma Tumors
Marwa Ismail, Stephen C. Craig, Raheel Ahmed, et al.
Diagnostics (2023) Vol. 13, Iss. 17, pp. 2727-2727
Open Access | Times Cited: 6
Marwa Ismail, Stephen C. Craig, Raheel Ahmed, et al.
Diagnostics (2023) Vol. 13, Iss. 17, pp. 2727-2727
Open Access | Times Cited: 6
Strategies to Enhance the Efficacy of T-Cell Therapy for Central Nervous System Tumors
Deepak Upreti, David Bakhshinyan, Darin Bloemberg, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 12
Deepak Upreti, David Bakhshinyan, Darin Bloemberg, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 12
The Current Landscape of Targeted Clinical Trials in Non-WNT/Non-SHH Medulloblastoma
David R. Ghasemi, Gudrun Fleischhack, Till Milde, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 679-679
Open Access | Times Cited: 8
David R. Ghasemi, Gudrun Fleischhack, Till Milde, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 679-679
Open Access | Times Cited: 8
Enhanced Survival of High-Risk Medulloblastoma-Bearing Mice after Multimodal Treatment with Radiotherapy, Decitabine, and Abacavir
Marieke Gringmuth, Jenny Walther, Sebastian Greiser, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3815-3815
Open Access | Times Cited: 7
Marieke Gringmuth, Jenny Walther, Sebastian Greiser, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3815-3815
Open Access | Times Cited: 7
